The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Aclaris Therapeutics Inc (ACRS) COM 00461U105   1,629,206 434,455 SH   SOLE   434,455 0 0
Bicara Therapeutics Inc. (BCAX) COM 055477103   11,315,799 568,919 SH   SOLE   568,919 0 0
Biomea Fusion Inc (BMEA) COM 09077A106   3,134,598 2,048,757 SH   SOLE   2,048,757 0 0
BridgeBio Pharma Inc. (BBIO) COM 10806X102   377,954,513 5,089,611 SH   SOLE   5,089,611 0 0
Compass Pathways Plc (CMPS) SPONSORED ADS 20451W101   7,920,818 1,432,336 SH   SOLE   1,432,336 0 0
Eupraxia Pharmaceuticals Inc. (EPRX) COM 29842P105   2,353,000 325,000 SH   SOLE   325,000 0 0
Marker Therapeutics, Inc. (MRKR) COM NEW 57055L206   422,981 325,370 SH   SOLE   325,370 0 0
Monte Rosa Therapeutics Inc (GLUE) COM 61225M102   25,590,673 1,555,664 SH   SOLE   1,555,664 0 0
OnKure Therapeutics, Inc. (OKUR) COM CL A 68277Q105   366,833 88,607 SH   SOLE   88,607 0 0
Syndax Pharmaceuticals, Inc. (SNDX) COM 87164F105   30,760,588 1,316,806 SH   SOLE   1,316,806 0 0
Scholar Rock Holding Corporation (SRRK) COM 80706P103   3,786,844 77,031 SH   SOLE   77,031 0 0
BridgeBio Oncology Therapeutics (BBOT) COM NEW 107924102   9,111,261 1,018,018 SH   SOLE   1,018,018 0 0
Urogen Pharma Ltd. (URGN) COM M96088105   1,941,840 108,000 SH   SOLE   108,000 0 0